Literature DB >> 21945171

Molecular genetic testing of uveal melanoma from routinely processed and stained cytology specimens.

Benjamin N Christopher1, Colleen M Cebulla, Paul E Wakely, Frederick H Davidorf, Mohamed H Abdel-Rahman.   

Abstract

In the following study we investigated the utility of molecular genetic testing of the DNA extracted from routinely stained and processed smears from uveal melanoma (UM). Smears from five uveal melanoma cell lines and 12 primary tumors were prepared and stained with Papanicolaou and Romanowsky stains. Genotyping was carried out utilizing 14 microsatellite markers on chromosomes 3, 6 and 8. Mutational screening for alterations in GNAQ and GNA11 genes was carried out by restriction fragment length polymorphism. The results were compared to those obtained through direct sequencing of frozen tumor tissues. High quality DNA was extracted from the stained slides with no difference in the efficiency of DNA extraction between the two staining techniques. The extracted DNA was of adequate quality for genotyping and mutational screening. DNA extracted from approximately 200 tumor cells is sufficient for reproducible testing of allelic imbalances and for studying the common somatic mutations in GNAQ and GNA11 genes. In conclusion, we presented the feasibility of utilizing routinely stained cytology smears from UM for molecular genetic testing. The DNA obtained is of sufficient quality to carry out genotyping for markers on chromosome 3, 6 and 8, as well as screening for somatic mutations in GNAQ and GNA11 genes.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945171      PMCID: PMC3937509          DOI: 10.1016/j.exer.2011.09.004

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  22 in total

1.  Frequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma.

Authors:  Mohamed H Abdel-Rahman; Benjamin N Christopher; Mohammed F Faramawi; Khaled Said-Ahmed; Carol Cole; Andrew McFaddin; Abhik Ray-Chaudhury; Nyla Heerema; Frederick H Davidorf
Journal:  Mod Pathol       Date:  2011-04-15       Impact factor: 7.842

2.  Evaluation of loss of heterozygosity/allelic imbalance scoring in tumor DNA.

Authors:  R I Skotheim; C B Diep; S M Kraggerud; K S Jakobsen; R A Lothe
Journal:  Cancer Genet Cytogenet       Date:  2001-05

3.  An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma.

Authors:  Michael D Onken; Lori A Worley; Meghan D Tuscan; J William Harbour
Journal:  J Mol Diagn       Date:  2010-04-22       Impact factor: 5.568

4.  Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival.

Authors:  Andrea G M Scholes; Bertil E Damato; Janice Nunn; Paul Hiscott; Ian Grierson; John K Field
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-03       Impact factor: 4.799

Review 5.  Changing concepts in the management of choroidal melanoma.

Authors:  Dennis M Robertson
Journal:  Am J Ophthalmol       Date:  2003-07       Impact factor: 5.258

6.  Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death.

Authors:  Bertil Damato; Justyna Dopierala; Annelies Klaasen; Marcory van Dijk; Julie Sibbring; Sarah E Coupland
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-01-31       Impact factor: 4.799

7.  Translating uveal melanoma cytogenetics into clinical care.

Authors:  Bertil Damato; Sarah E Coupland
Journal:  Arch Ophthalmol       Date:  2009-04

8.  Analytical and statistical methods to evaluate microsatellite allelic imbalance in small amounts of DNA.

Authors:  Robbert J C Slebos; David M Umbach; Courtney A Sommer; Geoffrey A Horner; Jane Y Choi; Jack A Taylor
Journal:  Lab Invest       Date:  2004-05       Impact factor: 5.662

9.  MET oncogene inhibition as a potential target of therapy for uveal melanomas.

Authors:  Mohamed H Abdel-Rahman; Getachew Boru; James Massengill; Manar M Salem; Frederick H Davidorf
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

10.  Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology.

Authors:  L Cawkwell; S M Bell; F A Lewis; M F Dixon; G R Taylor; P Quirke
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

View more
  1 in total

Review 1.  Genes and genetics in eye diseases: a genomic medicine approach for investigating hereditary and inflammatory ocular disorders.

Authors:  Mahavir Singh; Suresh C Tyagi
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.